Sheffield, B. S., Eaton, K., Emond, B., Lafeuille, M., Hilts, A., Lefebvre, P., . . . Cheema, P. (2023). Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current Oncology, 30(2), 2348-2366.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Sheffield, Brandon S., et al. "Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing Versus Single-Gene Testing Among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices."
Current Oncology 30, no. 2 (2023): 2348-2366.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Sheffield, Brandon S., et al. "Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing Versus Single-Gene Testing Among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices."
Current Oncology, vol. 30, no. 2, 2023, pp. 2348-2366.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.